Alpha Cognition Inc. Royalty Expense
Alpha Cognition Inc. (ACOG) had Royalty Expense of EUR 736.17 thousand as of 2026-04-10, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2026-08-13
- Alpha Cognition Inc. royalty expense for the quarter ending 2025-03-31 was $63.46K.
- Alpha Cognition Inc. royalty expense for fiscal 2025 was $1.03M.
- Alpha Cognition Inc. royalty expense for fiscal 2024 was $0.00.
USD
| Period end | Royalty Expense | Royalty Expense 3 month | Royalty Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $1.03M 10-K · filed 2026-03-31 | ||
| 2025-06-30 | $63.60K 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $63.46K 10-Q · filed 2025-05-15 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 |
EUR
| Period end | Royalty Expense |
|---|---|
| 2026-04-10 | 736.17K EUR 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |